Taipei Medical University Hospital is a healthcare facility in Taipei, Taiwan established in 1976.

There are 946 beds in Taipei Medical University Hospital.

During the past decade, Taipei Medical University Hospital conducted 115 clinical trials. In the 10-year time frame, 115 clinical trials started and 27 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 18 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taipei Medical University Hospital" #1 sponsor was "Taipei Medical University Hospital" with 25 trials, followed by "Taipei Medical University" with 13 trials sponsored, "National Taiwan University Hospital" with 11 trials sponsored, "Bayer" with 6 trials sponsored and "Pfizer" with 6 trials sponsored. Other sponsors include 78 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei Medical University Hospital" #1 collaborator was "PharmaEssentia" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Taipei Medical University Hospital" with 3 trials as a collaborator, "Chang Gung Memorial Hospital" with 2 trials as a collaborator and "China Medical University Hospital" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Taipei Medical University Hospital" are "Stroke" (8 trials), "Atrial Fibrillation" (4 trials), "Gastric Cancer" (4 trials), "Hepatocellular Carcinoma" (4 trials) and "Lung Cancer" (4 trials). Many other conditions were trialed in "Taipei Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Taipei Medical University Hospital" are "Drug" (82 trials), "Other" (22 trials), "Behavioral" (12 trials), "Biological" (12 trials) and "Device" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Filgotinib" (3 trials), "Finerenone (BAY94-8862)" (3 trials), "HD-tCES" (3 trials) and "Placebo to match filgotinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Taipei Medical University Hospital" are 135 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 56 active trials in "Taipei Medical University Hospital". 3 are not yet recruiting, 41 are recruiting, 10 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 55 completed trials in Taipei Medical University Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Taipei Medical University Hospital, 25 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 40 trials that are defined as “Not Applicable".

Taipei Medical University Hospital has several departments that took part in Clinical trials: "National Taiwan University Hospital - Hematology And Oncology" - 3 trials, "Department of Neurology, National Taiwan University Hospital" - 2 trials